Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6609 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-02-12 (cnbc.com)
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
Read more
2024-07-26 (borsaitaliana.it)
Biogen, share prices falling in New York
Telebag. finance. Biogen, share prices falling in New York.
Read more
2024-04-11 (statnews.com)
Gas prices are hurting biotech
The biggest index of biotech stocks turned red for the year, and it had nothing to do with clinical trials, drug revenues, or pharmaceutical mergers.
Read more
2024-03-09 (finmarket.ru)
S&P 500 Updates Record, Nasdaq Up 1.5%
US stock indices ended Tuesday's trading with strong growth. The stock markets of the largest Asia-Pacific countries are generally growing on Wednesday. Oil prices are rising on Wednesday morning, with Brent trading at $82.4 per barrel.
Read more
2022-11-30 (chron.com)
Biogen, Wayfair rise; CrowdStrike, NetApp fall
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes...
Read more
2021-06-09 (di.se)
The analyst after the crazy price rally: The companies that could be lucky - "important event"
On Monday, the Swedish biotechnology company Bioarctic rushed on the stock exchange after positive news for its American competitor Biogen. Now DNB's pharmaceutical analyst Patrik Ling points out two other pharmaceutical companies that could be facing substantial price increases. "It could be an important event for the company," he says of one of them.
Read more
2021-04-22 (proactiveinvestors.co.uk)
FTSE 100 perks up, as ECB sticks with stimulus measures and US jobless claims beat forecasts
The UK blue chip index shows some life while US investors are expected to pause to catch their breath
Read more
2020-01-01 (cnbc.com)
Bristol-Myers, Gilead, and Biogen hike US drug prices as the new year begins
Drugmakers including Bristol-Myers Squibb, Gilead Sciences, and Biogen hiked U.S. list prices on more than 50 drugs on Wednesday.
Read more
2017-04-12 (barrons.com)
Celgene, Biogen to Gain From Higher Prices
Heading into earnings, Biogen, Alexion Pharmaceuticals and Gilead Sciences could be in focus.
Read more
2014-12-17 (thestreet.com)
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
To prep investors for 2015, a list of clinical trial read-outs and FDA events expected to have a significant impact on stock prices in the first half of next year.
Read more
(benzinga.com)
10 Biggest Price Target Changes For Monday - Apple (NASDAQ:AAPL), Biogen (NASDAQ:BIIB) -
Benzinga simplifies the market for smarter investing
Read more
(breakingviews.com)
Biogen’s $7 bln deal goes smaller and safer
The biotech firm’s purchase of Reata will gift it a portfolio targeting rare diseases. With the US government’s Medicare insurance program recently freed to bargain down prices on best-selling drugs, such niche therapies have become more appealing versus potential blockbusters.
Read more